StockData
Concentra Group Holdings Parent, Inc. logo

Concentra Group Holdings Parent, Inc. (CON) stock analysis

CONNYSEServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3019% above fair value
$43.45+0.78 (+1.83%)

Close on Nov 11, 2026Market cap $5.54BP/E 25.9Yield 0.58%

StockData Score

Prices as of Nov 11, 2026How the score works

Value0Growth3Performance4Health2Dividend3

Mixed12 of 30 checks passed

Concentra Group Holdings Parent passes 12 of the 30 checks behind our score; 6 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
3/6
Past performance
4/6
Financial health
2/6
Dividend
3/6

What stands out

  • Return on capital over 10%

    Return on invested capital was 15.6%, above the 10% that usually covers the cost of capital.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 21.5% of total debt.

  • Guidance raised

    Concentra Group Holdings Parent raised its 2026 Revenue outlook on Aug 6, 2026.

  • Covered by free cash flow

    Dividends take 12.4% of free cash flow.

What to watch

  • Margin of safety under 20%

    The price is 19.2% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $43.45 is above our fair value estimate of $36.45.

  • High debt

    Debt is 300% of shareholders' equity, above the 40% we consider low.

  • Revenue growing under 10% a year

    Revenue grew 7.9% a year over the last three fiscal years, short of the 10% we look for.

Valuation0/6
  • P/E above its 5-year median

    Concentra Group Holdings Parent's P/E of 25.9 is above its own 5-year median of 16.4.

  • P/E above the industry

    Concentra Group Holdings Parent's P/E of 25.9 is above the Health Services median of 23.9.

  • EV/EBITDA above its 5-year median

    Concentra Group Holdings Parent's EV/EBITDA of 14.7 is above its 5-year median of 11.0.

  • P/B above the industry

    Concentra Group Holdings Parent's price-to-book of 10.93 is above the Health Services median of 5.14.

  • Trading above fair value

    The share price of $43.45 is above our fair value estimate of $36.45.

  • Margin of safety under 20%

    The price is 19.2% above fair value, so there is no margin of safety.

Growth3/6
  • Revenue growing under 10% a year

    Revenue grew 7.9% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -6.7% a year over the last three fiscal years.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 11.8% over the last twelve months; the Health Services median is 2.0%.

  • Guidance raised

    Concentra Group Holdings Parent raised its 2026 Revenue outlook on Aug 6, 2026.

  • Gross margin improving

    Gross margin was 29.9% over the last twelve months, against 28.4% a year earlier.

Past performance4/6
  • Return on equity

    Needs positive equity and five years of results.

  • Return on capital over 10%

    Return on invested capital was 15.6%, above the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Concentra Group Holdings Parent's return on equity of 48.5% is above the Health Services median of 3.6%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin above its 5-year average

    Net margin was 9.3% over the last twelve months, against a 5-year average of 9.0%.

  • Net margin above the industry

    Concentra Group Holdings Parent's net margin of 9.3% is above the Health Services median of -1.0%.

Financial health2/6
  • High debt

    Debt is 300% of shareholders' equity, above the 40% we consider low.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 21.5% of total debt.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term assets cover short-term debts

    Current assets are 1.30 times current liabilities.

  • Bankruptcy risk in the grey zone

    The Altman Z-score is 2.74; above 3 is the safe zone and below 1.8 the distress zone.

Dividend3/6
  • Pays a dividend

    Concentra Group Holdings Parent paid dividends worth 0.6% of the share price over the last twelve months.

  • Yield below Treasuries

    The 0.6% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Concentra Group Holdings Parent yields 0.6%.

  • Dividend stability

    Fewer than five years of dividend history.

  • Covered by earnings

    Dividends take 14.8% of net income.

  • Covered by free cash flow

    Dividends take 12.4% of free cash flow.

Scores of similar companies

Our estimate per share

$36.45

The share price is 19% above this estimate.

20%+ below
Near fair value
20%+ above
$43.45Price$36.45Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E21.7×16.4×23.9×$36.4344%
EV/EBITDA14.6×11.0×16.2×$43.2639%
Earnings power7.4% cost of equity––$20.6217%
Fair value$36.45100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 16.4
  • Health Services median 23.9

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$49.88M
Value traded per 1% price move
$31.04M

Downside

Low risk

Typical loss in a bad month
9.2%
Volatility (annualized)
29%
Sharpe ratio, 1 year
4.17
Beta to the S&P 500 (5Y)
0.50

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2021 to 2025

Gross margin

28.3%

Operating margin

15.4%

Net margin

7.7%

See a number that looks wrong?